Evidence map›Paper›PMID 39804054›Full record

ArticleEpilepsia2025

Age-associated differences in FIRES: Characterizing prodromal presentation and long-term outcomes via the web-based NORSE/FIRES Family Registry.

Karnig Kazazian, Nicolas Gaspard, Lawrence J Hirsch, Marissa Kellogg, Sara E Hocker, Nora Wong, Raquel Farias-Moeller, Krista Eschbach, Teneille E Gofton

Abstract read
In one paragraph

Article in Epilepsia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Karnig KazazianSchulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.ORCID https://orcid.org/0000-0001-6157-601X
Nicolas GaspardService de Neurologie, Université Libre de Bruxelles-Hôpital Erasme, Brussels, Belgium.
Lawrence J HirschComprehensive Epilepsy Center, Department of Neurology, Yale University, New Haven, Connecticut, USA.ORCID https://orcid.org/0000-0002-6333-832X
Marissa KelloggOregon Health and Science University, Portland, Oregon, USA.
Sara E HockerDivision of Critical Care Neurology, Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Nora WongNORSE Institute, Summit, New Jersey, USA.
Raquel Farias-MoellerMedical College of Wisconsin, Department of Neurology and Pediatrics, Children's Wisconsin, Milwaukee, Wisconsin, USA.ORCID https://orcid.org/0000-0001-8717-7703
Krista EschbachChildren's Hospital Colorado, University of Colorado, Aurora, Colorado, USA.
Teneille E GoftonSchulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.ORCID https://orcid.org/0000-0001-9001-4884

Funding

Robert N. Kohn NORSE Family Registry Memorial Research Fund
6 · The paper itself

Abstract

Febrile infection-related epilepsy syndrome (FIRES) is a rare clinical presentation of refractory status epilepticus following a febrile infection. This study analyzes data from the NORSE/FIRES Family Registry, an international web-based registry available in six languages with data entered by patients, families, and clinicians to explore clinical presentations, survivorship, and long-term outcomes in adult and pediatric FIRES patients. We characterize and examine differences in demographics, prodromal symptoms, seizure frequency, anti-seizure medications (ASMs), quality of life, cognition, mood, and anxiety in adults vs pediatric populations with FIRES. Eighty-six participants were included in the study. Pediatric patients (n = 54) were predominantly male (77.8%) and experienced a significantly higher post-FIRES seizure burden than adult survivors (67.7% ≥12 seizures/month in pediatrics vs 11.8% in adults, p <.001). Adults (n = 32) were more likely to be female (59.4%) and have flu-like prodromal symptoms (90.6%). At ≥6 months post-FIRES, both groups exhibited high ASM use, with the majority (87.5%) taking three or more medications. Pediatric patients reported worse mood and anxiety outcomes compared to adults (p <.005). Self-reported quality of life and cognition were rated as moderate across in adults (5.2/10) and pediatric (4.7/10) patients, although pediatric patients indicated poorer cognition. Our findings highlight the challenges in managing post-FIRES outcomes across different age groups, particularly in pediatric patients who face a higher seizure burden and report worse cognitive outcomes.

Indexed as

Prodromal SymptomsRegistriesStatus EpilepticusAdolescentAdultAgedAge FactorsAnticonvulsantsAnxietyChildChild, PreschoolFemaleHumansInternetMaleMiddle AgedAnticonvulsantsfebrile infection–related epilepsy syndromelong‐term outcomesnew‐onset refractory status epilepticusrefractory status epilepticus

Identifiers

PMID39804054
PMCPMC11908657

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.